Clinical trial

Single-Dose Study of a New Formulation of BIIB061

NCT02521545

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-07-01

PhasePHASE1

Study timeline

Study start (unknown)2015-07-01Date precision: month

Registry last updated2015-09-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Interventions

BIIB061DRUG

Sponsors & collaborators

Biogenlead sponsor

Mapped research locations

MadisonWisconsin, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02521545 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.